Los Angeles Capital Management LLC Voyager Therapeutics, Inc. Transaction History

Los Angeles Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$3.94 - $5.44 $237,298 - $327,640	-60,228 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$4.61 - $9.04 $211,575 - $414,890	-45,895 Reduced 43.25%	60,228 $283,000
Q4 2020 Feb 04, 2021	SELL	$7.15 - $12.28 $123,087 - $211,400	-17,215 Reduced 13.96%	106,123 $759,000
Q3 2020 Nov 02, 2020	BUY	$10.01 - $13.75 $27,857 - $38,266	2,783 Added 2.31%	123,338 $1.32 Million
Q2 2020 Aug 05, 2020	BUY	$8.05 - $14.21 $270,463 - $477,427	33,598 Added 38.64%	120,555 $1.52 Million
Q1 2020 May 04, 2020	BUY	$6.8 - $14.66 $254,979 - $549,706	37,497 Added 75.81%	86,957 $796,000
Q4 2019 Feb 07, 2020	BUY	$12.82 - $16.85 $471,391 - $619,574	36,770 Added 289.76%	49,460 $690,000
Q2 2019 Jul 29, 2019	BUY	$19.18 - $27.88 $243,394 - $353,797	12,690 New	12,690 $345,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $219M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.